| Literature DB >> 35809566 |
Leslie Magtanong1, Grace D Mueller1, Kevin J Williams2, Maximilian Billmann3, Katherine Chan4, David A Armenta1, Lauren E Pope1, Jason Moffat4, Charles Boone4, Chad L Myers5, James A Olzmann6, Steven J Bensinger7, Scott J Dixon8.
Abstract
Ferroptosis is an important mediator of pathophysiological cell death and an emerging target for cancer therapy. Whether ferroptosis sensitivity is governed by a single regulatory mechanism is unclear. Here, based on the integration of 24 published chemical genetic screens combined with targeted follow-up experimentation, we find that the genetic regulation of ferroptosis sensitivity is highly variable and context-dependent. For example, the lipid metabolic gene acyl-coenzyme A (CoA) synthetase long chain family member 4 (ACSL4) appears far more essential for ferroptosis triggered by direct inhibition of the lipid hydroperoxidase glutathione peroxidase 4 (GPX4) than by cystine deprivation. Despite this, distinct pro-ferroptotic stimuli converge upon a common lethal effector mechanism: accumulation of lipid peroxides at the plasma membrane. These results indicate that distinct genetic mechanisms regulate ferroptosis sensitivity, with implications for the initiation and analysis of this process in vivo.Entities:
Keywords: ACSL4; PUFA; ROS; cancer; ether lipid; ferroptosis; iron
Mesh:
Substances:
Year: 2022 PMID: 35809566 PMCID: PMC9481678 DOI: 10.1016/j.chembiol.2022.06.004
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 9.039